We are live on ! Find out more
TPCW

TD Private Client Wealth Portfolio holdings

AUM $4.82B
1-Year Est. Return 15.21%
This Fund
S&P 500
This Quarter Est. Return
-11.56%
1 Year Est. Return
+15.21%
3 Year Est. Return
+48.23%
5 Year Est. Return
+55.79%
10 Year Est. Return
AUM
$2.05B
AUM Growth
-$297M
Cap. Flow
-$1.11M
Cap. Flow %
-0.05%
Top 10 Hldgs %
28.12%
Holding
1,305
New
40
Increased
400
Reduced
622
Closed
82

Sector Composition

Rank Sector Weight
1 Technology 9.12%
2 Healthcare 8.3%
3 Financials 7.04%
4 Industrials 4.37%
5 Communication Services 3.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GMED icon
276
Globus Medical
GMED
$10.3B
$1.31M 0.06%
23,265
+22,844
+5,426% +$1.5M
LDOS icon
277
Leidos
LDOS
$14.3B
$1.3M 0.06%
12,941
+920
+8% +$95.3K
IWS icon
278
iShares Russell Mid-Cap Value ETF
IWS
$15.7B
$1.3M 0.06%
12,788
-9,196
-42% -$1.03M
SCHG icon
279
Schwab US Large-Cap Growth ETF
SCHG
$58.4B
$1.3M 0.06%
89,492
+15,360
+21% +$246K
NVS icon
280
Novartis
NVS
$294B
$1.27M 0.06%
15,006
+1,756
+13% +$154K
FICO icon
281
Fair Isaac
FICO
$28.7B
$1.27M 0.06%
3,164
-251
-7% -$99K
BA icon
282
Boeing
BA
$165B
$1.26M 0.06%
9,247
+2,356
+34% +$348K
WST icon
283
West Pharmaceutical
WST
$24B
$1.26M 0.06%
4,173
-643
-13% -$209K
EEM icon
284
iShares MSCI Emerging Markets ETF
EEM
$28.1B
$1.25M 0.06%
31,140
-4,247
-12% -$178K
BFAM icon
285
Bright Horizons
BFAM
$3.96B
$1.24M 0.06%
14,691
-690
-4% -$68.6K
SRE icon
286
Sempra
SRE
$61.5B
$1.21M 0.06%
16,108
-644
-4% -$51.7K
CCEP icon
287
Coca-Cola Europacific Partners
CCEP
$46.4B
$1.2M 0.06%
23,313
+2,072
+10% +$106K
ESNT icon
288
Essent Group
ESNT
$6.04B
$1.18M 0.06%
30,417
-3
-0% -$122
ELAN icon
289
Elanco Animal Health
ELAN
$12.4B
$1.18M 0.06%
59,930
-2,842
-5% -$67.3K
BIIB icon
290
Biogen
BIIB
$29.7B
$1.17M 0.06%
5,752
+724
+14% +$148K
QCOM icon
291
Qualcomm
QCOM
$176B
$1.17M 0.06%
9,164
+368
+4% +$50K
IDXX icon
292
Idexx Laboratories
IDXX
$42.5B
$1.16M 0.06%
3,310
-215
-6% -$87.7K
DE icon
293
Deere & Co
DE
$165B
$1.15M 0.06%
3,827
-45
-1% -$16.6K
EAGG icon
294
iShares ESG Aware US Aggregate Bond ETF
EAGG
$4.96B
$1.15M 0.06%
23,405
-74
-0.3% -$3.66K
DBX icon
295
Dropbox
DBX
$6.77B
$1.14M 0.06%
54,162
+70
+0.1% +$1.51K
BERY
296
DELISTED
Berry Global Group, Inc.
BERY
$1.13M 0.06%
22,549
+124
+0.6% +$6.43K
EA icon
297
Electronic Arts
EA
$52.4B
$1.13M 0.06%
9,275
-756
-8% -$96.4K
BIO icon
298
Bio-Rad Laboratories Class A
BIO
$8.44B
$1.12M 0.05%
2,270
+81
+4% +$42.2K
MRSH
299
Marsh
MRSH
$85B
$1.12M 0.05%
7,203
+419
+6% +$67.1K
DT icon
300
Dynatrace
DT
$12B
$1.11M 0.05%
28,255
-641
-2% -$25.5K

Similar funds

TD Private Client Wealth's Q2 2022 Portfolio in Review

As of Q2 2022, TD Private Client Wealth held 1,305 positions worth $2.05B, down 13% from $2.35B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

TD Private Client Wealth's Q2 2022 filing shows 40 new, 400 increased, 622 reduced and 82 closed positions. Its largest new stake was Vanguard Mortgage-Backed Securities ETF: 30,703 shares worth $1.47M. The largest sale was Vanguard Dividend Appreciation ETF, an estimated $10.1M.

By sector, the portfolio is most concentrated in Technology at 9.1% of assets, down from 9.8% a quarter earlier, followed by Healthcare and Financials.

  • TD Private Client Wealth's largest Q2 2022 buy was Vanguard Mortgage-Backed Securities ETF: 30,703 shares worth $1.47M.
  • TD Private Client Wealth added most to iShares 7-10 Year Treasury Bond ETF in Q2 2022, an estimated $25.4M increase.
  • TD Private Client Wealth's biggest Q2 2022 reduction was Vanguard Dividend Appreciation ETF, cutting an estimated $10.1M.
  • TD Private Client Wealth fully exited Invesco National AMT-Free Municipal Bond ETF in Q2 2022, selling an estimated $1.63M.
  • TD Private Client Wealth's ten largest holdings make up 28% of its $2.05B portfolio in Q2 2022.
  • TD Private Client Wealth opened 40 new positions and closed 82 in Q2 2022.
  • TD Private Client Wealth's portfolio value fell 13% quarter-over-quarter to $2.05B.

Based on TD Private Client Wealth's 13F filing for Q2 2022, filed 16 Aug 2024.